The City of Hope Hematology-Oncology fellowship has been ACGME-accredited since the mid-1970's. It was the last free-standing fellowship independent of an internal medicine training program until its affiliation with Harbor-UCLA Internal Medicine. The strengths of this fellowship have always been the variety and viability of patient populations, the excellent accessibility of faculty teaching and opportunity for fellows to participate in clinical trials and even write clinical trials. Graduates excel in both clinical oncology skills and academic training to be able to thrive in either private or academic practice.
In the first year of fellowship, the emphasis is placed on acquiring a knowledge base of solid tumor oncology, both in the outpatient and inpatient settings. In addition, there is an early exposure to Bone Marrow Transplantation.
The experience shifts towards a significant amount of research time during the second year. Six months are spent in the continuity hematology-oncology clinics at Harbor-UCLA. A portion of this time is also reserved for work on the general hematology consult service. Harbor-UCLA offers excellent preparation for board certification in hematology.
In the third year, fellows have an opportunity to participate in elective rotations and continued research. Fellows are afforded the opportunity to explore oncology related research opportunities during the dedicated research months. City of Hope provides fellows many avenues for both for clinical and basic science research; fellows have pursued a diverse array of projects in the past and have earned numerous distinctions in the process, including national awards at American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO).